Health tech deals
GSK has agreed to acquire Canadian drugmaker 35Pharma for up to US$950m, gaining an experimental treatment for pulmonary arterial hypertension. The drug, HS235, has completed Phase 1 testing in healthy volunteers. GSK said it plans to move the treatment into studies targeting pulmonary arterial hypertension or another form of pulmonary hypertension linked to heart failure. [...]
Hims & Hers Health beat Q4 earnings forecasts, though shares fell 2 per cent in aftermarket trading after the telehealth firm issued full-year guidance largely in line and a softer first quarter. The company reported Q4 earnings per share of US$0.08, ahead of analyst expectations of $0.05. Revenue rose to US$617.8m, compared with consensus forecasts [...]
LTIMindtree has secured a seven-year US$100m medtech deal to develop and support hearing aids and related digital tools for a European medical technology company. The Indian IT services company said the Europe-based client, which provides hearing solutions, has not been named. Under the agreement, LTIMindtree will develop and support the client’s main hearing [...]
Hims & Hers has agreed to buy Eucalyptus in a deal worth up to US$1.15bn, expanding its international digital health reach beyond the US. Eucalyptus, founded in 2019, operates consumer health brands including Juniper and Pilot across Australia, the UK, Germany, Japan and Canada. The company says it has served more than 775,000 customers and [...]
Sanofi has backed Altesa BioSciences in a US$75m series B round for the rhinovirus-focused biotech led by former acting FDA commissioner Brett Giroir. The funding will mainly support a phase 2b study, a mid-stage clinical trial, of vapendavir, an oral antiviral pill for patients with chronic obstructive pulmonary disease (COPD), a long-term lung condition that [...]
The UK is offering £20m in addiction tech grants to cut harm and deaths linked to drug and alcohol addiction. Delivered through Innovate UK, the funding sits within the government’s Addiction Healthcare Goals programme and will support new medicines, medical devices, wearables, virtual reality therapies, treatment apps and AI-enabled tools. Around 15,000 people die each [...]
Nul has raised US$1m in seed funding for its telehealth platform that combines clinical care and prescription medication to help people reduce their alcohol consumption. The UK healthtech startup, founded by Matus Maar, is building a service that integrates clinical care, prescription medication, digital treatment pathways and behavioural support. It offers a fully remote subscription [...]
Garner Health has raised US$118m in Series D funding to expand its doctor ranking platform, taking total funding to US$200m. Founded in 2019, the digital care navigation company uses data analytics and artificial intelligence to help employers and employees identify high-quality, cost-effective healthcare providers. It then creates financial incentives for patients to see those doctors. [...]
Anterior has raised an additional US$40m, taking its total funding to US$64m. The oversubscribed round included existing investors NEA and Sequoia Capital, along with new backers FPV and Kinnevik. The New York-based company is integrating AI into clinical workflows for health plans, using a clinician-led deployment approach to improve accuracy and adoption. Since [...]
Neurent Medical has raised €62.5m (US$74m) in an oversubscribed Series C financing round to support commercial expansion, broaden clinical evidence and advance its product and indication pipeline. The round was led by MVM Partners, with significant participation from Sofinnova Partners, and included continued support from existing investors EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners [...]
